Cargando…
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
Glioblastoma is the most malignant tumor and has high mortality rate. The methylated prompter of MGMT results in chemotherapy sensitivity for these patients. However, there are still other factors that affected the prognosis for the glioblastoma patients with similar MGMT methylation status. We deve...
Autores principales: | Wang, Wen, Zhang, Lu, Wang, Zheng, Yang, Fan, Wang, Haoyuan, Liang, Tingyu, Wu, Fan, Lan, Qing, Wang, Jiangfei, Zhao, Jizong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342529/ https://www.ncbi.nlm.nih.gov/pubmed/27588397 http://dx.doi.org/10.18632/oncotarget.11726 |
Ejemplares similares
-
LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016) -
A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
por: Chai, Rui-Chao, et al.
Publicado: (2019) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023) -
A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
por: Cheng, Wen, et al.
Publicado: (2015) -
MGMT promoter methylation in Peruvian patients with glioblastoma
por: Belmar-Lopez, Carolina, et al.
Publicado: (2018)